Sebastian-delaCruz, M.; Olazagoitia-Garmendia, A.; Gonzalez-Moro, I.; Santin, I.; Garcia-Etxebarria, K.; Castellanos-Rubio, A.
Implication of m6A mRNA Methylation in Susceptibility to Inflammatory Bowel Disease. Epigenomes 2020, 4, 16.
https://doi.org/10.3390/epigenomes4030016
AMA Style
Sebastian-delaCruz M, Olazagoitia-Garmendia A, Gonzalez-Moro I, Santin I, Garcia-Etxebarria K, Castellanos-Rubio A.
Implication of m6A mRNA Methylation in Susceptibility to Inflammatory Bowel Disease. Epigenomes. 2020; 4(3):16.
https://doi.org/10.3390/epigenomes4030016
Chicago/Turabian Style
Sebastian-delaCruz, Maialen, Ane Olazagoitia-Garmendia, Itziar Gonzalez-Moro, Izortze Santin, Koldo Garcia-Etxebarria, and Ainara Castellanos-Rubio.
2020. "Implication of m6A mRNA Methylation in Susceptibility to Inflammatory Bowel Disease" Epigenomes 4, no. 3: 16.
https://doi.org/10.3390/epigenomes4030016
APA Style
Sebastian-delaCruz, M., Olazagoitia-Garmendia, A., Gonzalez-Moro, I., Santin, I., Garcia-Etxebarria, K., & Castellanos-Rubio, A.
(2020). Implication of m6A mRNA Methylation in Susceptibility to Inflammatory Bowel Disease. Epigenomes, 4(3), 16.
https://doi.org/10.3390/epigenomes4030016